CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways 
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE)...
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
MENDHAM, N.J., and SOUTH SAN FRANCISCO, Calif, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Assembly Biosciences, Inc....
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern TimeLOWELL, Mass., Oct. 19, 2021 (GLOBE...
InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19
Initial portion of the grant amounts to EUR 25.8 millionRemainder of the grant will be awarded in three additional milestone-dependent...
Artizan Biosciences Announces Appointment of Dr. Bridget Martell as President and Chief Executive Officer
Artizan Biosciences, Inc. Bridget Martell, M.A., M.D., President and Chief Executive Officer, Artizan Biosciences, Inc. NEW HAVEN, Conn., Oct. 19,...
AIM ImmunoTech Submits IND and Accompanying Fast Track Application for Phase 2 Trial of Ampligen in Patients with Locally Advanced or Metastatic Late-Stage Pancreatic Cancer
OCALA, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has submitted...
Challenge Testing of Kraig Biocraft Laboratories’ Disease Resistant Silkworms Underway
Immunity enhanced silkworms provide licensing opportunities into the broader $14B1 silk industry ANN ARBOR, Mich., Oct. 19, 2021 (GLOBE NEWSWIRE)...
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)
Oral Presentation to Highlight AMT-191 for Fabry DiseaseLEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 19, 2021 (GLOBE NEWSWIRE) -- uniQure...
Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene Therapy Treatment for Cystic Fibrosis
Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene Therapy Treatment for Cystic Fibrosis Oxford,...
Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liquid Biopsy Assays
Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liquid Biopsy Assays Two clinical studies...
Amryt Announces New Patents for Oleogel-S10 and Mycapssa®
Amryt Announces New Patents for Oleogel-S10 and Mycapssa® DUBLIN, Ireland, and Boston MA, October 19, 2021, Amryt (Nasdaq: AMYT, AIM:...
COMPASS Pathways is granted new US patent for crystalline psilocybin
London, UK – 19 October 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating...
Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation
Toronto, Ontario--(Newsfile Corp. - October 19, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Medicat Announces Enterprise Vaccine Verification Software and Managed Services
Preparing for the Corporate Vaccine Mandate ATLANTA--(BUSINESS WIRE)--Medicat announced today the availability of its world-class enterprise vaccine verification software and...
Onward and Upward: CLS Holdings USA, Inc. Announces September Results with a Continued Focus on Brand Growth
LAS VEGAS, NV / ACCESSWIRE / October 19, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Pharnext Strengthens its Management Team with Three Key Appointments to Support Ongoing Development of PXT3003 Toward Approval and Commercialization
PARIS, FRANCE / ACCESSWIRE / October 19, 2021 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-stage clinical...
Newborn Town Announced its Operating Figures for the First Three Quarters; Expected Revenue Growth of Over 115% YoY; MAU of Social Apps Reached 20.43 million
HONG KONG, CHINA / ACCESSWIRE / October 19, 2021 / On 18 October, Newborn Town Inc. (HK:9911), China's top social...
NeoGenomics’ Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays
Two clinical studies including interventional RaDaR™ studyFT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a...
Planet 13 Announces One Month Adjustment to Vesting Schedules of Restricted Stock Units
LAS VEGAS, NV / ACCESSWIRE / October 18, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...